1. Home
  2. VIRT vs RXRX Comparison

VIRT vs RXRX Comparison

Compare VIRT & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIRT
  • RXRX
  • Stock Information
  • Founded
  • VIRT 2008
  • RXRX 2013
  • Country
  • VIRT United States
  • RXRX United States
  • Employees
  • VIRT N/A
  • RXRX N/A
  • Industry
  • VIRT Investment Bankers/Brokers/Service
  • RXRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • VIRT Finance
  • RXRX Health Care
  • Exchange
  • VIRT Nasdaq
  • RXRX Nasdaq
  • Market Cap
  • VIRT 2.8B
  • RXRX 2.6B
  • IPO Year
  • VIRT 2015
  • RXRX 2021
  • Fundamental
  • Price
  • VIRT $33.47
  • RXRX $5.70
  • Analyst Decision
  • VIRT Hold
  • RXRX Buy
  • Analyst Count
  • VIRT 7
  • RXRX 4
  • Target Price
  • VIRT $41.43
  • RXRX $7.25
  • AVG Volume (30 Days)
  • VIRT 907.8K
  • RXRX 70.1M
  • Earning Date
  • VIRT 10-29-2025
  • RXRX 11-06-2025
  • Dividend Yield
  • VIRT 2.87%
  • RXRX N/A
  • EPS Growth
  • VIRT 122.21
  • RXRX N/A
  • EPS
  • VIRT 4.40
  • RXRX N/A
  • Revenue
  • VIRT $2,617,631,000.00
  • RXRX $64,596,000.00
  • Revenue This Year
  • VIRT N/A
  • RXRX $24.17
  • Revenue Next Year
  • VIRT N/A
  • RXRX $20.96
  • P/E Ratio
  • VIRT $7.61
  • RXRX N/A
  • Revenue Growth
  • VIRT 42.88
  • RXRX 30.14
  • 52 Week Low
  • VIRT $29.82
  • RXRX $3.79
  • 52 Week High
  • VIRT $45.77
  • RXRX $12.36
  • Technical
  • Relative Strength Index (RSI)
  • VIRT 38.37
  • RXRX 51.41
  • Support Level
  • VIRT $32.93
  • RXRX $5.58
  • Resistance Level
  • VIRT $33.71
  • RXRX $7.18
  • Average True Range (ATR)
  • VIRT 0.77
  • RXRX 0.65
  • MACD
  • VIRT 0.26
  • RXRX -0.01
  • Stochastic Oscillator
  • VIRT 69.38
  • RXRX 31.04

About VIRT Virtu Financial Inc.

Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

Share on Social Networks: